col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


78 Results       Page 1

 [1] 
American Chemical Society: ACS Infectious Diseases
  original article Date Title Authors   All Authors
1 [GO] 2023―May―11 hACE2-Induced Allosteric Activation in SARS-CoV versus SARS-CoV-2 Spike Assemblies Revealed by Structural Dynamics Chengbo Chen, Richard Zhu, Edgar A. Hodge, Marco A. Díaz-Salinas, Adam Nguyen, James B. Munro, Kelly K. Lee
2 [GO] 2023―May―05 SARS-CoV-2 Binding to Terminal Sialic Acid of Gangliosides Embedded in Lipid Membranes Geetanjali Negi, Anurag Sharma, Monika Chaudhary, Divya Gupta, Krishnan H. Harshan, Nagma Parveen
3 [GO] 2023―Apr―13 Sphingosine Kinases Promote Ebola Virus Infection and Can Be Targeted to Inhibit Filoviruses, Coronaviruses, and Arenaviruses Using Late Endocytic Trafficking to Enter Cells Corina M. Stewart, Yuxia Bo, Kathy Fu, Mable Chan, Robert Kozak, Kim Yang-Ping Apperley, et al. (+6)
4 [GO] 2023―Apr―03 Identification of Human Host Substrates of the SARS-CoV-2 Mpro and PLpro Using Subtiligase N-Terminomics Shu Y. Luo, Eman W. Moussa, Joaquin Lopez-Orozco, Alberto Felix-Lopez, Ray Ishida, Nawell Fayad, et al. (+6)
5 [GO] 2023―Mar―13 Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Hyeon-Min Cha, Uk-Il Kim, Soo Bin Ahn, Myoung Kyu Lee, Haemi Lee, Hyungtae Bang, et al. (+5)
6 [GO] 2023―Feb―03 Hybridization Chain Reaction Lateral Flow Assays for Amplified Instrument-Free At-Home SARS-CoV-2 Testing Samuel J. Schulte, Jining Huang, Niles A. Pierce
7 [GO] 2022―Oct―31 High-Throughput Assay for Identifying Diverse Antagonists of the Binding Interaction between the ACE2 Receptor and the Dynamic Spike Proteins of SARS-CoV-2 Rachel M. Sammons, Amanda L. Bohanon, Anvith Kowtha, Audrey Dejong, Eun Jeong Cho, Tamer S. Kaoud, Kevin N. Dalby
8 [GO] 2022―Oct―11 α2,6-Sialylation Is Upregulated in Severe COVID-19, Implicating the Complement Cascade Rui Qin, Emma Kurz, Shuhui Chen, Briana Zeck, Luis Chiribogas, Dana Jackson, et al. (+8)
9 [GO] 2022―Sep―26 Broad Tricyclic Ring Inhibitors Block SARS-CoV-2 Spike Function Required for Viral Entry Sneha Ratnapriya, Anthony R. Braun, Héctor Cervera Benet, Danielle Carlson, Shilei Ding, Carolyn N. Paulson, et al. (+5)
10 [GO] 2022―Sep―21 Virus-Like Particles of SARS-CoV-2 as Virus Surrogates: Morphology, Immunogenicity, and Internalization in Neuronal Cells Chandra Shekhar Kumar, Balwant Singh, Zaigham Abbas Rizvi, Hilal Ahmad Parray, Jitender Kumar Verma, Sukanya Ghosh, et al. (+4)
11 [GO] 2022―Sep―12 Chemoenzymatic Synthesis of SARS-CoV-2 Homogeneous O-Linked Glycopeptides for Exploring Their Inhibition Functions Yongheng Rong, Xingyun Wang, Weian Mao, Fang Yuan, Min Chen, Shengjun Wang, et al. (+4)
12 [GO] 2022―Aug―31 A New iNKT-Cell Agonist-Adjuvanted SARS-CoV-2 Subunit Vaccine Elicits Robust Neutralizing Antibody Responses Ya-Qian Li, Cheng Yan, Xi-Feng Wang, Mao-Ying Xian, Guo-Qing Zou, Xiao-Fei Gao, et al. (+2)
13 [GO] 2022―Aug―18 Sialic Acid and Fucose Residues on the SARS-CoV-2 Receptor-Binding Domain Modulate IgG Antibody Reactivity Ebba Samuelsson, Ekaterina Mirgorodskaya, Kristina Nyström, Malin Bäckström, Jan-Åke Liljeqvist, Rickard Nordén
14 [GO] 2022―Aug―08 Two Years into the COVID-19 Pandemic: Lessons Learned Severino Jefferson Ribeiro da Silva, Jessica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, Klarissa Miranda Guarines, Caroline Targino Alves da Silva, Poliana Gomes da Silva, et al. (+6)
15 [GO] 2022―Jul―22 Plasmonic Fluor-Enhanced Antigen Arrays for High-Throughput, Serological Studies of SARS-CoV-2 Abraham J. Qavi, Chao Wu, Matthew Lloyd, Mohammad Mahabub-Uz Zaman, Jingyi Luan, Claire Ballman, et al. (+4)
16 [GO] 2022―Jul―13 Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors Aliakbar Khalili Yazdi, Paknoosh Pakarian, Sumera Perveen, Taraneh Hajian, Vijayaratnam Santhakumar, Albina Bolotokova, et al. (+2)
17 [GO] 2022―Jul―12 Raman Fingerprints of the SARS-CoV-2 Delta Variant and Mechanisms of Its Instantaneous Inactivation by Silicon Nitride Bioceramics Giuseppe Pezzotti, Eriko Ohgitani, Yuki Fujita, Hayata Imamura, Masaharu Shin-Ya, Tetsuya Adachi, et al. (+6)
18 [GO] 2022―Jun―29 Sec61 Inhibitor Apratoxin S4 Potently Inhibits SARS-CoV-2 and Exhibits Broad-Spectrum Antiviral Activity Marie O. Pohl, Laura Martin-Sancho, Ranjala Ratnayake, Kris M. White, Laura Riva, Qi-Yin Chen, et al. (+19)
19 [GO] 2022―Jun―24 Adjuvant-Protein Conjugate Vaccine with Built-In TLR7 Agonist on S1 Induces Potent Immunity against SARS-CoV-2 and Variants of Concern Ru-Yan Zhang, Shi-Hao Zhou, Chen-Bin He, Jian Wang, Yu Wen, Ran-Ran Feng, et al. (+3)
20 [GO] 2022―Jun―01 Suite of TMPRSS2 Assays for Screening Drug Repurposing Candidates as Potential Treatments of COVID-19 Jonathan H. Shrimp, John Janiszewski, Catherine Z. Chen, Miao Xu, Kelli M. Wilson, Stephen C. Kales, et al. (+11)
21 [GO] 2022―May―24 Pyronaridine Protects against SARS-CoV-2 Infection in Mouse Ana C. Puhl, Giovanni F. Gomes, Samara Damasceno, Andre S. Godoy, Gabriela D. Noske, Aline M. Nakamura, et al. (+14)
22 [GO] 2022―Apr―15 A Highly Potent SARS-CoV-2 Blocking Lectin Protein Recep E. Ahan, Alireza Hanifehnezhad, Ebru Ş. Kehribar, Tuba C. Oguzoglu, Katalin Földes, Cemile E. Özçelik, et al. (+8)
23 [GO] 2022―Apr―11 Drug-Repurposing Screening Identified Tropifexor as a SARS-CoV-2 Papain-like Protease Inhibitor Chunlong Ma, Yanmei Hu, Yuyin Wang, Juliana Choza, Jun Wang
24 [GO] 2022―Mar―30 Microfluidic Antibody Affinity Profiling Reveals the Role of Memory Reactivation and Cross-Reactivity in the Defense Against SARS-CoV-2 Viola Denninger, Catherine K. Xu, Georg Meisl, Alexey S. Morgunov, Sebastian Fiedler, Alison Ilsley, et al. (+9)
25 [GO] 2022―Mar―14 The Pandemic Response Box─Accelerating Drug Discovery Efforts after Disease Outbreaks Kirandeep Samby, Dominique Besson, Anirban Dutta, Buddhadev Patra, Angelique Doy, Paul Glossop, et al. (+10)
26 [GO] 2022―Mar―09 A Recombinant Subunit Vaccine Induces a Potent, Broadly Neutralizing, and Durable Antibody Response in Macaques against the SARS-CoV-2 P.1 (Gamma) Variant Albert To, Teri Ann S. Wong, Michael M. Lieberman, Karen Thompson, Aquena H. Ball, Laurent Pessaint, et al. (+11)
27 [GO] 2022―Feb―24 Exploring Noncovalent Protease Inhibitors for the Treatment of Severe Acute Respiratory Syndrome and Severe Acute Respiratory Syndrome-Like Coronaviruses Brendan T. Freitas, Daniil A. Ahiadorme, Rahul S. Bagul, Ian A. Durie, Samir Ghosh, Jarvis Hill, et al. (+13)
28 [GO] 2022―Feb―23 Intrinsically Disordered Proteins: Perspective on COVID-19 Infection and Drug Discovery Rumiana Tenchov, Qiongqiong Angela Zhou
29 [GO] 2022―Feb―08 Emerging Vaccine-Breakthrough SARS-CoV-2 Variants Rui Wang, Jiahui Chen, Yuta Hozumi, Changchuan Yin, Guo-Wei Wei
30 [GO] 2021―Dec―03 Structure and Mutations of SARS-CoV-2 Spike Protein: A Focused Overview Rukmankesh Mehra, Kasper P. Kepp
31 [GO] 2021―Oct―21 Cowpea Mosaic Virus Nanoparticle Vaccine Candidates Displaying Peptide Epitopes Can Neutralize the Severe Acute Respiratory Syndrome Coronavirus Oscar A. Ortega-Rivera, Sourabh Shukla, Matthew D. Shin, Angela Chen, Veronique Beiss, Miguel A. Moreno-Gonzalez, et al. (+5)
32 [GO] 2021―Oct―19 Antiviral Potential of the Antimicrobial Drug Atovaquone against SARS-CoV-2 and Emerging Variants of Concern Madalina Elena Carter-Timofte, Rozanne Arulanandam, Naziia Kurmasheva, Kathy Fu, Geneviève Laroche, Zaid Taha, et al. (+24)
33 [GO] 2021―Oct―07 Reductionism Ad Absurdum: The Misadventures of Structural Biology in the Time of Coronavirus Dmitri Svetlov, Irina Artsimovitch
34 [GO] 2021―Sep―27 A Closer Look into FDA-EUA Approved Diagnostic Techniques of Covid-19 Hyunju Oh, Hyunjeong Ahn, Anubhav Tripathi
35 [GO] 2021―Sep―09 Inhibitors of L-Type Calcium Channels Show Therapeutic Potential for Treating SARS-CoV-2 Infections by Preventing Virus Entry and Spread Marco R. Straus, Miya K. Bidon, Tiffany Tang, Javier A. Jaimes, Gary R. Whittaker, Susan Daniel
36 [GO] 2021―Aug―26 Recognition of Divergent Viral Substrates by the SARS-CoV-2 Main Protease Elizabeth A. MacDonald, Gary Frey, Mark N. Namchuk, Stephen C. Harrison, Stephen M. Hinshaw, Ian W. Windsor
37 [GO] 2021―Aug―02 Salicylanilides Reduce SARS-CoV-2 Replication and Suppress Induction of Inflammatory Cytokines in a Rodent Model Steven Blake, Namir Shaabani, Lisa M. Eubanks, Junki Maruyama, John T. Manning, Nathan Beutler, et al. (+4)
38 [GO] 2021―Jul―30 Nasal Microbiota Imbalance as a Contributory Link in the Emergence of COVID-19 Associated Mucormycosis Rachna Singh, Anjna Kumari
39 [GO] 2021―Jul―28 Reproducible Breath Metabolite Changes in Children with SARS-CoV-2 Infection Amalia Z. Berna, Elikplim H. Akaho, Rebecca M. Harris, Morgan Congdon, Emilie Korn, Samuel Neher, et al. (+3)
40 [GO] 2021―Jul―14 Immunogenicity and Protective Efficacy of a Highly Thermotolerant, Trimeric SARS-CoV-2 Receptor Binding Domain Derivative Sameer Kumar Malladi, Unnatiben Rajeshbhai Patel, Raju S. Rajmani, Randhir Singh, Suman Pandey, Sahil Kumar, et al. (+28)
41 [GO] 2021―Jun―21 The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors Tomáš Otava, Michal Šála, Fengling Li, Jindřich Fanfrlík, Kanchan Devkota, Sumera Perveen, et al. (+6)
42 [GO] 2021―Jun―15 Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2 Scott B. Biering, Erik Van Dis, Eddie Wehri, Livia H. Yamashiro, Xammy Nguyenla, Claire Dugast-Darzacq, et al. (+17)
43 [GO] 2021―Jun―03 Science at Its Best in the Time of the COVID-19 Pandemic Alon Herschhorn, Ashley T. Haase
44 [GO] 2021―May―26 Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp Jianyuan Zhao, Yongxin Zhang, Minghua Wang, Qian Liu, Xiaobo Lei, Meng Wu, et al. (+10)
45 [GO] 2021―May―21 The SARS-CoV-2 SSHHPS Recognized by the Papain-like Protease Nathanael D. Reynolds, Nathalie M. Aceves, Jinny L. Liu, Jaimee R. Compton, Dagmar H. Leary, Brendan T. Freitas, et al. (+5)
46 [GO] 2021―May―12 Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2 Damir Bojadzic, Oscar Alcazar, Jinshui Chen, Sung-Ting Chuang, Jose M. Condor Capcha, Lina A. Shehadeh, Peter Buchwald
47 [GO] 2021―Apr―21 Antibody Affinity Governs the Inhibition of SARS-CoV-2 Spike/ACE2 Binding in Patient Serum Sebastian Fiedler, Monika A. Piziorska, Viola Denninger, Alexey S. Morgunov, Alison Ilsley, Anisa Y. Malik, et al. (+7)
48 [GO] 2021―Apr―16 Human Cathelicidin Inhibits SARS-CoV-2 Infection: Killing Two Birds with One Stone Cheng Wang, Shaobo Wang, Daixi Li, Peiqin Chen, Songling Han, Gaomei Zhao, et al. (+7)
49 [GO] 2021―Mar―30 Inhibition of Human Coronaviruses by Antimalarial Peroxides Ayan Kumar Ghosh, Halli Miller, Konstance Knox, Madhuchhanda Kundu, Kelly J. Henrickson, Ravit Arav-Boger
50 [GO] 2021―Mar―17 Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2 Simon Fink, Felix Ruoff, Aaron Stahl, Matthias Becker, Philipp Kaiser, Bjoern Traenkle, et al. (+15)
51 [GO] 2021―Mar―08 Learning from COVID-19 to Tackle Antibiotic Resistance Manica Balasegaram
52 [GO] 2021―Mar―01 Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses Yanmei Hu, Chunlong Ma, Tommy Szeto, Brett Hurst, Bart Tarbet, Jun Wang
53 [GO] 2021―Feb―13 Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19 Kas Steuten, Heeyoung Kim, John C. Widen, Brett M. Babin, Ouma Onguka, Scott Lovell, et al. (+10)
54 [GO] 2021―Jan―27 Detection of Bacterial Coinfection in COVID-19 Patients Is a Missing Piece of the Puzzle in the COVID-19 Management in Indonesia Anggia Prasetyoputri
55 [GO] 2021―Jan―15 Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin Tiffany Tang, Javier A. Jaimes, Miya K. Bidon, Marco R. Straus, Susan Daniel, Gary R. Whittaker
56 [GO] 2021―Jan―13 Early Returns on Small Molecule Therapeutics for SARS-CoV-2 Mark N. Namchuk
57 [GO] 2020―Dec―22 Therapeutic Potential of Nitazoxanide: An Appropriate Choice for Repurposing versus SARS-CoV-2? Andrew V. Stachulski, Joshua Taujanskas, Sophie L. Pate, Rajith K. R. Rajoli, Ghaith Aljayyoussi, Shaun H. Pennington, et al. (+7)
58 [GO] 2020―Dec―21 The SARS-CoV-2 Cytopathic Effect Is Blocked by Lysosome Alkalizing Small Molecules Kirill Gorshkov, Catherine Z. Chen, Robert Bostwick, Lynn Rasmussen, Bruce Nguyen Tran, Yu-Shan Cheng, et al. (+20)
59 [GO] 2020―Dec―15 Integrating Proteomics for Facilitating Drug Identification and Repurposing During an Emerging Virus Pandemic Brayden G. Schindell, Meagan Allardice, Sandhini Lockman, Jason Kindrachuk
60 [GO] 2020―Dec―09 Recent Insights into Emerging Coronavirus: SARS-CoV-2 Zifang Shang, Siew Yin Chan, William J. Liu, Peng Li, Wei Huang
61 [GO] 2020―Dec―02 Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies Jonathan P. Davies, Katherine M. Almasy, Eli F. McDonald, Lars Plate
62 [GO] 2020―Nov―18 Detection, Mapping, and Proteotyping of SARS-CoV-2 Coronavirus with High Resolution Mass Spectrometry Nicholas L. Dollman, Justin H. Griffin, Kevin M. Downard
63 [GO] 2020―Nov―13 High-Throughput Screening of an FDA-Approved Drug Library Identifies Inhibitors against Arenaviruses and SARS-CoV-2 Weiwei Wan, Shenglin Zhu, Shufen Li, Weijuan Shang, Ruxue Zhang, Hao Li, et al. (+4)
64 [GO] 2020―Nov―12 COVID-19 in the Developing World: Is the Immune Response to α-Gal an Overlooked Factor Mitigating the Severity of Infection? Adnan Hodžić, José de la Fuente, Alejandro Cabezas-Cruz
65 [GO] 2020―Oct―28 Targeting Crucial Host Factors of SARS-CoV-2 Anil Mathew Tharappel, Subodh Kumar Samrat, Zhong Li, Hongmin Li
66 [GO] 2020―Sep―23 Targeting polyamines inhibits coronavirus infection by reducing cellular attachment Mason R Firpo, Vincent Mastrodomenico, Grant Hawkins, Matthieu Prot, Laura Levillayer, Thomas Gallagher, et al. (+2)
67 [GO] 2020―Sep―18 Structural, biophysical and biochemical elucidation of the SARS-CoV-2 nonstructural protein 3 macro domain Meng-Hsuan Lin, San-Chi Chang, Yi-Chih Chiu, Bo-Chen Jiang, Tsung-Han Wu, Chun-Hua Hsu
68 [GO] 2020―Aug―12 Comparative analysis of primer-probe sets for RT-qPCR of COVID-19 causative virus (SARS-CoV-2) Yujin Jung, Gun-Soo Park, Jun Hye Moon, Keun Bon Ku, Seung-Hwa Beak, Chang-Seop Lee, et al. (+12)
69 [GO] 2020―Aug―04 Clinical and Laboratory Diagnosis of SARS-CoV-2, the Virus Causing COVID-19 Severino Jefferson Ribeiro da Silva, Caroline silva, Klarissa Guarines, Renata Mendes, Keith M. Pardee, Alain Kohl, Lindomar Pena
70 [GO] 2020―Jul―20 Old drugs for a new virus: repurposed approaches for combating COVID-19 Sirle Saul, Shirit Einav
71 [GO] 2020―Jul―17 Current and Perspective Diagnostic Techniques for COVID-19 Xi Yuan, Chengming Yang, Qian He, Junhu Chen, Dongmei Yu, Jie Li, et al. (+5)
72 [GO] 2020―Jun―02 Current Perspective of Antiviral Strategies against COVID-19 Bintou Ahmadou Ahidjo, Marcus Loe, Yan Ling Ng, Chee Keng Mok, Justin Jang Hann Chu
73 [GO] 2020―Jun―01 COVID-19 and Other Pandemics: How Might They Be Prevented? Eric Oldfield, Satish R. Malwal
74 [GO] 2020―May―28 Endogenous Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in COVID-19 Patients Alexey Polonikov
75 [GO] 2020―May―19 Characterization and noncovalent inhibition of the deubiquitinase and deISGylase activity of SARS-CoV-2 papain-like protease Brendan T Freitas, Ian A Durie, Jackelyn Murray, Jaron E Longo, Holden C Miller, David Crich, et al. (+3)
76 [GO] 2020―May―15 Are Quaternary Ammonium Compounds, the Workhorse Disinfectants, Effective against Severe Acute Respiratory Syndrome-Coronavirus-2? Cassandra L. Schrank, Kevin P. C. Minbiole, William M. Wuest
77 [GO] 2020―May―10 COVID-19: Living through Another Pandemic Essam Eldin A. Osman, Peter L. Toogood, Nouri Neamati
78 [GO] 2020―Apr―15 Correction: Immunodominant SARS Coronavirus Epitopes in Humans Elicited Both Enhancing and Neutralizing Effects on Infection in Non-human Primates Qidi Wang, Lianfeng Zhang, Kazuhiko Kuwahara, Li Li, Zijie Liu, Taisheng Li, et al. (+8)
 [1] 

78 Results       Page 1



[de][en]

Last change 2023―Apr―13 19:50:14 UTC

© Daten-Quadrat 2022       Done in 0.008 sec